High total metabolic tumor volume in PET/CT predicts worse prognosis in diffuse large B cell lymphoma patients with bone marrow involvement in rituximab era
Moo-Kon Song1, Deok-Hwan Yang2, Gyeong-Won Lee3, Sung-Nam Lim4, Seunghyeon Shin5, Kyoung June Pak5, Seong Young Kwon6, Hye Kyung Shim7, Bong-Hoi Choi8, In-Suk Kim9, Dong-Hoon Shin10, Seong-Geun Kim1, So-Yeon Oh1
1Department of Hematology-Oncology, Pusan National University Yangsan Hospital Medical Research Institute, Yangsan, Republic of Korea
2Department of Hematology, Chonnam National University Hwasun Hospital, Hwasun, Republic of Korea
3Department of Hematology, Gyeong-Sang National University Hospital, school of medicine, Gyeong-Sang National University Jinju, Republic of Korea
4Department of Hematology, Busan Haeundae Paik Hospital, Busan, Republic of Korea
5Department of Nuclear Medicine, Pusan National University Hospital, Busan, Republic of Korea
6Department of Nuclear Medicine, Chonnam National University Hwasun Hospital, Hwasun, Republic of Korea
7Department of Nuclear Medicine, Busan Haeundae Paik Hospital, Busan, Republic of Korea
8Department of Nuclear Medicine, Gyeongsang National University Hospital, Jinju, Republic of Korea
9Department of Laboratory Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea
10Department of Pathology, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Leukemia Research
Tập 42
1-6
Thông tin tác giả